PressDigest

Valeant seeks help of top shareholders for sweetened Salix bid

Valeant Pharmaceuticals is understood to be considering issuing new preferred equity to some of its biggest shareholders to finance a sweetened, all-cash bid for Salix Pharmaceuticals.

WSJ Logo
Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With TrumpExternal link

Pro Bono or Pro Nono? Law Firms Split on Fulfilling Deals With Trump